Literature DB >> 32595791

The Role of Syk in Inflammatory Response of Human Abdominal Aortic Aneurysm Tissue.

Ryo Kanamoto1, Hiroki Aoki2, Aya Furusho3, Hiroyuki Otsuka1, Yusuke Shintani1, Satoru Tobinaga1, Shinichi Hiromatsu1, Yoshihiro Fukumoto3, Hiroyuki Tanaka1.   

Abstract

Objective: Inflammatory response is central to pathogenesis of abdominal aortic aneurysm (AAA). Recently, we reported that Syk, a signaling molecule in inflammatory cells, promotes AAA development in a mouse model. In this study, we aimed to investigate the role of Syk in human AAA pathogenesis. Materials and
Methods: We obtained human AAA wall samples during open surgical aortic repair at Kurume University Hospital. Immunohistochemical analyses of AAA samples were performed for Syk activation and cell type markers. Ex vivo culture of human AAA tissue was utilized to evaluate the effect of P505-15, a Syk inhibitor, on secretions of interleukin-6 (IL-6) and matrix metalloproteinases (MMPs).
Results: Immunohistochemical analysis showed infiltration of B cells, T cells, and macrophages in AAA samples. Syk activation was localized mainly in B cells and part of macrophages. AAA tissue in culture secreted IL-6, MMP-9, and MMP-2 without any stimulation. The unstimulated secretions of IL-6, MMP-9, and MMP-2 were insensitive to P505-15. Secretions of IL-6 and MMP-9 were enhanced by exogenous normal human immunoglobulin G (IgG), which was suppressed by P505-15, whereas secretion of MMP-2 was insensitive to IgG or P505-15.
Conclusion: These results demonstrate an important role of Syk for IgG-dependent inflammatory response in human AAA.
Copyright © 2020 Annals of Vascular Diseases.

Entities:  

Keywords:  Syk; abdominal aortic aneurysm; inflammation

Year:  2020        PMID: 32595791      PMCID: PMC7315237          DOI: 10.3400/avd.oa.20-00009

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  21 in total

Review 1.  Fc receptor biology.

Authors:  M Daëron
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 2.  Translational Relevance and Recent Advances of Animal Models of Abdominal Aortic Aneurysm.

Authors:  Jean Sénémaud; Giuseppina Caligiuri; Harry Etienne; Sandrine Delbosc; Jean-Baptiste Michel; Raphaël Coscas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-01-05       Impact factor: 8.311

Review 3.  Targets for medical therapy to limit abdominal aortic aneurysm progression.

Authors:  Theophilus I Emeto; Sai-Wang Seto; Jonathan Golledge
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

Review 4.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

Review 5.  B lymphocytes in abdominal aortic aneurysms.

Authors:  Lili Zhang; Yi Wang
Journal:  Atherosclerosis       Date:  2015-07-21       Impact factor: 5.162

6.  Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation.

Authors:  Hui-fang Zhou; Huimin Yan; Paula Bertram; Ying Hu; Luke E Springer; Robert W Thompson; John A Curci; Dennis E Hourcade; Christine T N Pham
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

Review 7.  Getting Syk: spleen tyrosine kinase as a therapeutic target.

Authors:  Robert L Geahlen
Journal:  Trends Pharmacol Sci       Date:  2014-06-26       Impact factor: 14.819

Review 8.  Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.

Authors:  Hiroki Aoki; Koichi Yoshimura; Masunori Matsuzaki
Journal:  J Mol Med (Berl)       Date:  2007-05-24       Impact factor: 4.599

9.  Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm.

Authors:  Monica B Pagano; Hui-fang Zhou; Terri L Ennis; Xiaobo Wu; John D Lambris; John P Atkinson; Robert W Thompson; Dennis E Hourcade; Christine T N Pham
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

Review 10.  Targeting Syk in Autoimmune Rheumatic Diseases.

Authors:  Guo-Min Deng; Vasileios C Kyttaris; George C Tsokos
Journal:  Front Immunol       Date:  2016-03-07       Impact factor: 7.561

View more
  1 in total

1.  Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development.

Authors:  Laura Lopez-Sanz; Susana Bernal; Luna Jimenez-Castilla; Ignacio Prieto; Sara La Manna; Sergio Gomez-Lopez; Luis Miguel Blanco-Colio; Jesus Egido; Jose Luis Martin-Ventura; Carmen Gomez-Guerrero
Journal:  Clin Transl Med       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.